13 research outputs found

    Metabolism of gestobutanoil, a novel drug of progestin group

    No full text
    The aim of the study is to evaluate the metabolism of progestin drug Gestobutanoil in the experiment with administration of tablet dosage form containing Gestobutanoil (2 mg), to experimental animals (rats and rabbits). Materials and Methods. There was performed analysis of biomatrix obtained from different species of animals: female rats weighing 200.0Β±60.0 g and female rabbits weighing 3.0Β±0.2 kg, which were administered different doses of the drug, single or multiple. Metabolites were identified using high performance liquid chromatography-mass spectrometry (HPLC-MS). Results. The analysis shows that Gestobutanoil is rapidly metabolized into 17Ξ±-acetoxy-3Ξ²-hydroxy-6-methylpregna-4,6-dien-20-one (AMP-17) and 17-hydroxy-6-methylpregna-1,4-diene-3,20-dione in the form of acetate (MA). The steroid core of Gestobutanoil has the butyric acid radical in the 3Ξ² position. This radical cleavage underlies biotransformation of Gestobutanoil. The obtained pharmacokinetic parameters for metabolites have demonstrated that Gestobutanoil has a stepwise nature of metabolism: the time to reach the maximum concentration of AMP-17 is 1.5 h, MA β€” 3 h. Also AMP-17 proves to penetrate into the peripheral tissues better than MA. Conclusion. The data obtained speak of a unique, different from other gestagens, metabolism of Gestobutanoil. Unlike the known progestogen medroxyprogesterone acetate whose main route of transformation is hydroxylation of the steroid nucleus of the molecule with rather high bioavailability in an unchanged state, Gestobutanoil shows rapid biotransformation into metabolites AMP-17 and MA manifesting their own gestagenic activity with release of butyric acid, which, in turn, may produce a calming effect on the central nervous system. Β© 2019, Privolzhsky Research Medical University. All rights reserved

    HPLC-MS Method for Simultaneous Quantitative Determination of an Innovative Russian Gestagen and its Metabolites in Rat and Rabbit Blood Sera

    No full text
    An HPLC-MS method for simultaneous quantitative determination of a novel gestagenic pharmaceutical and two of its metabolites in rat and rabbit blood sera was developed and validated. The method was selective and specific. The detection limit for all analytes was 5 ng/mL; lower limit of quantitation, 10 ng/mL. Calibration curves for all analytes had the form y = ax + b. The correlation coefficients were >0.99. Matrix effects, degree of extraction, and stability of analytes in standard solutions, analytical samples, and the biomatrix with multiple freezeβ€”thaw cycles were studied. Β© 2019, Springer Science+Business Media, LLC, part of Springer Nature

    Π’Π­Π–Π₯-МБ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠ° ΠΎΠ΄Π½ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ количСствСнного опрСдСлСния ΠΈΠ½Π½ΠΎΠ²Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ отСчСствСнного гСстагСна ΠΈ Π΅Π³ΠΎ ΠΌΠ΅Ρ‚Π°Π±ΠΎΠ»ΠΈΡ‚ΠΎΠ² Π² сывороткС ΠΊΡ€ΠΎΠ²ΠΈ крыс ΠΈ ΠΊΡ€ΠΎΠ»ΠΈΠΊΠΎΠ²

    No full text
    A method for simultaneous quantitative determination of a new gestagenic pharmacological agent and its two metabolites in the blood serum of rats and rabbits by HPLC-MS has been developed and validated. The method is selective and specific. The detection limits of all analytes were 5 ng/mL and the lower limits of quantification were 10 ng/mL. The calibration curves for all analytes had the form of y = ax + b with correlation coefficients > 0.99. The matrix effect and degree of extraction were studied, as well as the stability of analytes in standard solutions, ready-for-analysis samples, and biomatrix during repeated freezing and thawing cycles.Π Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Π½Π° ΠΈ Π²Π°Π»ΠΈΠ΄ΠΈΡ€ΠΎΠ²Π°Π½Π° Π’Π­Π–Π₯-МБ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠ° ΠΎΠ΄Π½ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ количСствСнного опрСдСлСния Π½ΠΎΠ²ΠΎΠ³ΠΎ гСстагСнного фармакологичСского срСдства ΠΈ 2 Π΅Π³ΠΎ ΠΌΠ΅Ρ‚Π°Π±ΠΎΠ»ΠΈΡ‚ΠΎΠ² Π² сывороткС ΠΊΡ€ΠΎΠ²ΠΈ крыс ΠΈ ΠΊΡ€ΠΎΠ»ΠΈΠΊΠΎΠ². ΠœΠ΅Ρ‚ΠΎΠ΄ сСлСктивСн ΠΈ спСцифичСн. ΠŸΡ€Π΅Π΄Π΅Π» обнаруТСния для всСх Π°Π½Π°Π»ΠΈΡ‚ΠΎΠ² составил 5 Π½Π³/ΠΌΠ», Π½ΠΈΠΆΠ½ΠΈΠΉ ΠΏΡ€Π΅Π΄Π΅Π» количСствСнного опрСдСлСния - 10 Π½Π³/ΠΌΠ». Для всСх Π°Π½Π°Π»ΠΈΡ‚ΠΎΠ² ΠΊΠ°Π»ΠΈΠ±Ρ€ΠΎΠ²ΠΎΡ‡Π½Ρ‹Π΅ ΠΊΡ€ΠΈΠ²Ρ‹Π΅ ΠΈΠΌΠ΅Π»ΠΈ Π²ΠΈΠ΄: y = ax + b. ΠšΠΎΡΡ„Ρ„ΠΈΡ†ΠΈΠ΅Π½Ρ‚Ρ‹ коррСляции > 0,99. Π˜Π·ΡƒΡ‡Π΅Π½Ρ‹ эффСкт влияния ΠΌΠ°Ρ‚Ρ€ΠΈΡ†Ρ‹ ΠΈ ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒ извлСчСния, Π° Ρ‚Π°ΠΊΠΆΠ΅ ΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΡŒ Π°Π½Π°Π»ΠΈΡ‚ΠΎΠ² Π² стандартных растворах, Π³ΠΎΡ‚ΠΎΠ²Ρ‹Ρ… ΠΏΡ€ΠΎΠ±Π°Ρ… ΠΈ Π±ΠΈΠΎΠΌΠ°Ρ‚Ρ€ΠΈΡ†Π΅ ΠΏΡ€ΠΈ ΠΌΠ½ΠΎΠ³ΠΎΠΊΡ€Π°Ρ‚Π½ΠΎΠΌ Π·Π°ΠΌΠΎΡ€Π°ΠΆΠΈΠ²Π°Π½ΠΈΠΈ ΠΈ Ρ€Π°Π·ΠΌΠΎΡ€Π°ΠΆΠΈΠ²Π°Π½ΠΈΠΈ

    Energy and force parameters of tube drawing over a special curved, self-adjusting mandrel

    No full text
    15.00; Translated from Russian (Izv. Vyssh. Uchebn. Zaved., Chern. Metall. 1988 (6) p. 42-46)Available from British Library Document Supply Centre- DSC:9022.06(BISI-Trans--26923)T / BLDSC - British Library Document Supply CentreSIGLEGBUnited Kingdo

    Evaluation of the toxicity of new progestogen gestobutanoil in experiments on rats and mice

    No full text
    A toxicological study of gestobutanoil tablets containing 0.002 g of progestogen 17a-acetoxy-3b-hydroxy-6-methylpregna-4,6-dien-20-one in the form of butyl ester as an active pharmaceutical substance for peroral administration was carried out on mice and rats of both sex. It was found that LD 50 of the drug exceeded 5 g/kg, which indicated low toxicity of gestobutanoil tablets. Chronic intragastric administration of gestabutanoil in doses of 2.5 and 25 mg/kg for 30 days did not cause clinically significant changes in the integral state of animals, biochemical and hematological parameters, except for an increase in the concentration of direct bilirubin in the blood by 37-40% (p - 0,01), which is a characteristic biochemical feature of gestagen-containing drugs. The observed tendency to decrease in the locomotor, orientation, and research activity and emotional behavior of female rats upon the administration of gestabutanoil for a month indicates its possible antistress effect on the central nervous system of rats. A specific effect of the drug in the studied doses 2.5 and 25 mg/kg on the target organs (uterus and ovaries) was revealed, as manifested by decidualization of the endometrium and a decrease in folliculogenesis in the ovaries. Since no toxic effect was observed in doses of 2.5 and 25 mg/kg (which exceeded the therapeutic dose 10 and 100 times, respectively), die equivalent dose for humans can be 0.064 mg/kg/day, according to the animal-to-human dose conversion formula. Β© 2018 Izdatel'stvo Meditsina. All rights reserved

    Characteristics of rolling rail strip in universal four-roll pass

    No full text
    30.00; Translated from Russian (Stal' 1987 (9) p. 53-57)Available from British Library Document Supply Centre- DSC:9022.06(BISI-Trans--26437)T / BLDSC - British Library Document Supply CentreSIGLEGBUnited Kingdo
    corecore